Paper Details
- Home
- Paper Details
Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.
Author: AbbateAntonio, BuckleyLeo F, ChiabrandoJuan Guido, KadariyaDinesh, MarkleyRoshanak, TrankleCory R, Van TassellBenjamin, VecchiéAlessandra, WohlfordGeorge F, de ChazalHoracio Medina
Original Abstract of the Article :
Interleukin-1 (IL-1) receptor antagonist (anakinra) has been shown to be effective in steroid-dependent recurrent pericarditis resistant to nonsteroidal anti-inflammatory drugs (NSAIDs) and colchicine. We sought to evaluate the acute efficacy of anakinra given early in patients with acute pericardit...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1097/FJC.0000000000000847
データ提供：米国国立医学図書館（NLM）
Anakinra: A Potential New Treatment for Acute Pericarditis
Acute pericarditis is a painful inflammation of the sac surrounding the heart. This research explores the potential of anakinra, an interleukin-1 (IL-1) receptor antagonist, as a rapid and effective treatment for acute pericarditis. The study investigates the acute effects of anakinra in patients experiencing severe pain despite standard treatments with nonsteroidal anti-inflammatory drugs (NSAIDs) and colchicine. The findings demonstrate that anakinra significantly reduced pain intensity within 24 hours, suggesting it may be a valuable tool for managing acute pericarditis.
Anakinra Demonstrates Promising Results in Acute Pericarditis
The study's findings indicate that anakinra, an IL-1 receptor antagonist, can provide rapid and significant pain relief in patients with acute pericarditis. The treatment demonstrated a marked reduction in pain intensity within 24 hours, even in patients who had not responded to conventional therapies. This suggests that anakinra may be a valuable alternative or adjunctive treatment option for managing acute pericarditis, potentially improving patient comfort and overall well-being.
A Camel's View on Pericarditis Treatment
Acute pericarditis can be a painful and debilitating condition, much like a camel struggling with a thorn in its foot. This research offers a potential solution, suggesting that anakinra can provide swift and effective relief, akin to a healing balm. By targeting the inflammatory processes underlying pericarditis, anakinra may pave the way for more comfortable and efficient management of this condition.
Dr.Camel's Conclusion
This study provides encouraging evidence for the potential of anakinra as a rapid and effective treatment for acute pericarditis. The findings suggest that anakinra may offer a valuable new approach to managing this painful condition, potentially improving patient comfort and overall well-being.
Date :
- Date Completed 2021-01-13
- Date Revised 2021-01-13
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.